CoronaCentral
Dashboard
Recent
Epidemiology
Forecasting & Modelling
Infection Reports
Transmission
Contact Tracing
Prevalence
Prevention
Surveillance
Clinical
Clinical Reports
Risk Factors
Long Haul
Pediatrics
Medical Specialties
Recommendations
Imaging
Diagnostics
Healthcare Workers
Biology
Molecular Biology
Immunology
Model Systems & Tools
Non-human
Treatment
Therapeutics
Drug Targets
Vaccines
Clinical Trials
Medical Devices
Psychology
Policy
Health Policy
Communication
Inequality
Education
Other Articles
Reviews
Meta-analysis
Comments & Editorials
CDC Weekly Reports
Book Chapters
News
Non-medical
Retractions
Misinformation
Mentions
Drugs
Genes or Proteins
Genetic Variation
Locations
Medical Specialties
Prevention Methods
Risk Factors
Species
Symptoms
Test Types
Transmission Types
Vaccine Types
Viral Lineages
FAQs
Feedback
Select virus of interest
Drug Targets
Share
Research discussing potential therapeutic coronavirus targets
Published and Preprint Papers
Filter
Export
Title
CD14 and CSF1R as developmental molecular targets for the induction of osteoarthritis.
Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation.
SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2.
The molecular mechanism of non-covalent inhibitor WU-04 targeting SARS-CoV-2 3CLpro and computational evaluation of its effectiveness against mainstream coronaviruses.
Inhibition of the Cellular Deubiquitinase UCHL1 Suppresses SARS-CoV-2 Replication.
Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach.
Identification of a novel inhibitor of SARS-CoV-2 main protease: an in silico, biochemical, and cell-based approach.
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals.
10
15
20
25
30